1. W W. Tourtellotte, The cerebrospinal fluid in multiple sclerosis, in: “Handbook of Clinical Neurology”, vol 3:47 J.C. Koetsier, ed., pp 79–130, Elsevier, Amsterdam (1985).
2. H. Link, CSF IgG and its congeners, in “Advances in CSF Protein Research and Diagnosis”, E.J. Thompson, ed., pp 49–88, MTP Press, Lancaster (1987).
3. H. Link, Cerebrospinal fluid in immunological CNS diseases, in: “Clinical Neuroimmunology”, J.A. Aarli, W.M.H. Behan and P.O. Behan, eds, pp 444–466, Blackwell, Oxford (1987).
4. O. C. Fagnart, C. J. M. Sindic, and C. Laterre, Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases, J.Neuroimmunol., 19:119–132 (1988).
5. C. C. Czerkinsky, L. A. Nilsson, and H. Nygren, A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells, J.Immunol.Meth., 65:109–121 (1983).